$3.55
0.144.04%
al cierre: Sep 4, 5:00 PM EST
$3.33
-0.22-6.2%
After hour: Sep 4, 7:57 PM EST
CollPlant Biotechnologies (CLGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.40 | $-1.90 | $2.50 | $0.60 |
| Actual | $-2.10 | $-2.50 | $-2.50 | $-2.30 |
| Surprise | +12.5% | -31.6% | -200.0% | -483.3% |
| Revenue | ||||
| Estimate | $1.4M | $6.8M | $13.7M | $8.9M |
| Actual | $73000 | $60000 | $77000 | $179000 |
| Surprise | -94.8% | -99.1% | -99.4% | -98.0% |
| Metric | Q2 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-0.24 |
| Revenue | |
| Consensus | $1.5M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 29, 2026 | $-2.10 | $-2.40 | 12.5 % |
| Q4 | Mar 26, 2026 | $-2.50 | $-1.90 | -31.6 % |
| Q3 | Nov 26, 2025 | $-2.50 | $2.50 | -200.0 % |
| Q2 | Aug 20, 2025 | $-2.30 | $0.60 | -483.3 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 29, 2026 | $73.00K | $1.40M | -94.8 % |
| Q4 | Mar 26, 2026 | $60.00K | $6.77M | -99.1 % |
| Q3 | Nov 26, 2025 | $77.00K | $13.73M | -99.4 % |
| Q2 | Aug 20, 2025 | $179.00K | $8.91M | -98.0 % |